238 related articles for article (PubMed ID: 19800133)
1. Early response to selective serotonin reuptake inhibitors in panic disorder is associated with a functional 5-HT1A receptor gene polymorphism.
Yevtushenko OO; Oros MM; Reynolds GP
J Affect Disord; 2010 Jun; 123(1-3):308-11. PubMed ID: 19800133
[TBL] [Abstract][Full Text] [Related]
2. Determinants of pharmacodynamic trajectory of the therapeutic response to paroxetine in Japanese patients with panic disorder.
Ishiguro S; Watanabe T; Ueda M; Saeki Y; Hayashi Y; Akiyama K; Saito A; Kato K; Inoue Y; Shimoda K
Eur J Clin Pharmacol; 2011 Dec; 67(12):1213-21. PubMed ID: 21688171
[TBL] [Abstract][Full Text] [Related]
3. Association of a functional 1019C>G 5-HT1A receptor gene polymorphism with panic disorder with agoraphobia.
Rothe C; Gutknecht L; Freitag C; Tauber R; Mössner R; Franke P; Fritze J; Wagner G; Peikert G; Wenda B; Sand P; Jacob C; Rietschel M; Nöthen MM; Garritsen H; Fimmers R; Deckert J; Lesch KP
Int J Neuropsychopharmacol; 2004 Jun; 7(2):189-92. PubMed ID: 14984628
[TBL] [Abstract][Full Text] [Related]
4. Association of the functional -1019C/G 5-HT1A polymorphism with prefrontal cortex and amygdala activation measured with 3 T fMRI in panic disorder.
Domschke K; Braun M; Ohrmann P; Suslow T; Kugel H; Bauer J; Hohoff C; Kersting A; Engelien A; Arolt V; Heindel W; Deckert J
Int J Neuropsychopharmacol; 2006 Jun; 9(3):349-55. PubMed ID: 16316476
[TBL] [Abstract][Full Text] [Related]
5. Sertraline versus paroxetine in the treatment of panic disorder: an acute, double-blind noninferiority comparison.
Bandelow B; Behnke K; Lenoir S; Hendriks GJ; Alkin T; Goebel C; Clary CM
J Clin Psychiatry; 2004 Mar; 65(3):405-13. PubMed ID: 15096081
[TBL] [Abstract][Full Text] [Related]
6. Potential involvement of NET polymorphism in serotonin/norepinephrine reuptake inhibitor response in panic disorder.
Park HJ; Kim SK; Kang WS; Kim YJ; Cho AR; Park JK
Nord J Psychiatry; 2016; 70(4):314-7. PubMed ID: 26508020
[TBL] [Abstract][Full Text] [Related]
7. Does 5-HT restrain panic? A tryptophan depletion study in panic disorder patients recovered on paroxetine.
Bell C; Forshall S; Adrover M; Nash J; Hood S; Argyropoulos S; Rich A; Nutt DJ
J Psychopharmacol; 2002 Mar; 16(1):5-14. PubMed ID: 11949771
[TBL] [Abstract][Full Text] [Related]
8. Early improvement predicts endpoint remission status in sertraline and placebo treatments of panic disorder.
Pollack MH; Rapaport MH; Fayyad R; Otto MW; Nierenberg AA; Clary CM
J Psychiatr Res; 2002; 36(4):229-36. PubMed ID: 12191627
[TBL] [Abstract][Full Text] [Related]
9. Sertraline treatment of panic disorder: response in patients at risk for poor outcome.
Pollack MH; Rapaport MH; Clary CM; Mardekian J; Wolkow R
J Clin Psychiatry; 2000 Dec; 61(12):922-7. PubMed ID: 11206597
[TBL] [Abstract][Full Text] [Related]
10. Depression and comorbid panic in primary care patients.
DeVeaugh-Geiss AM; West SL; Miller WC; Sleath B; Kroenke K; Gaynes BN
J Affect Disord; 2010 Jun; 123(1-3):283-90. PubMed ID: 19828203
[TBL] [Abstract][Full Text] [Related]
11. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
Foster RH; Goa KL
CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224
[TBL] [Abstract][Full Text] [Related]
12. A naturalistic long-term comparison study of selective serotonin reuptake inhibitors in the treatment of panic disorder.
Dannon PN; Iancu I; Lowengrub K; Gonopolsky Y; Musin E; Grunhaus L; Kotler M
Clin Neuropharmacol; 2007; 30(6):326-34. PubMed ID: 18090457
[TBL] [Abstract][Full Text] [Related]
13. Current concepts in the treatment of panic disorder.
Sheehan DV
J Clin Psychiatry; 1999; 60 Suppl 18():16-21. PubMed ID: 10487251
[TBL] [Abstract][Full Text] [Related]
14. Antipanic efficacy of paroxetine and polymorphism within the promoter of the serotonin transporter gene.
Perna G; Favaron E; Di Bella D; Bussi R; Bellodi L
Neuropsychopharmacology; 2005 Dec; 30(12):2230-5. PubMed ID: 16034444
[TBL] [Abstract][Full Text] [Related]
15. The effect of selective serotonin reuptake inhibitor treatment of panic disorder on emergency room and laboratory resource utilization.
Roy-Byrne PP; Clary CM; Miceli RJ; Colucci SV; Xu Y; Grudzinski AN
J Clin Psychiatry; 2001 Sep; 62(9):678-82. PubMed ID: 11681762
[TBL] [Abstract][Full Text] [Related]
16. The role of SSRIs in panic disorder.
Sheehan DV; Harnett-Sheehan K
J Clin Psychiatry; 1996; 57 Suppl 10():51-8; discussion 59-60. PubMed ID: 8917132
[TBL] [Abstract][Full Text] [Related]
17. Long-term evaluation of paroxetine, clomipramine and placebo in panic disorder. Collaborative Paroxetine Panic Study Investigators.
Lecrubier Y; Judge R
Acta Psychiatr Scand; 1997 Feb; 95(2):153-60. PubMed ID: 9065681
[TBL] [Abstract][Full Text] [Related]
18. Pharmacologic effect of imipramine, paroxetine, and sertraline on 35% carbon dioxide hypersensitivity in panic patients: a double-blind, random, placebo-controlled study.
Bertani A; Perna G; Arancio C; Caldirola D; Bellodi L
J Clin Psychopharmacol; 1997 Apr; 17(2):97-101. PubMed ID: 10950471
[TBL] [Abstract][Full Text] [Related]
19. A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder. Collaborative Paroxetine Panic Study Investigators.
Lecrubier Y; Bakker A; Dunbar G; Judge R
Acta Psychiatr Scand; 1997 Feb; 95(2):145-52. PubMed ID: 9065680
[TBL] [Abstract][Full Text] [Related]
20. Panic disorder, treatment with selective serotonin reuptake inhibitors, and cholesterol levels.
Herrán A; Ramírez ML; Carrera M; García-Unzueta MT; Sierra-Biddle D; Rodríguez-Cabo B; Ayestarán A; Hoyuela F; Vázquez-Barquero JL
J Clin Psychopharmacol; 2006 Oct; 26(5):538-40. PubMed ID: 16974205
[No Abstract] [Full Text] [Related]
[Next] [New Search]
